Publications by authors named "Graham Gordon"

Claim this Profile
A
AI-driven reclassification of multiple sclerosis progression.
Habib Ganjgahi, Dieter A Häring, Piet Aarden, Gordon Graham, Yang Sun

Nat Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for worsening and improvement in multiple sclerosis using a multistate model.
Alex Ocampo, Farhad Hatami, Jelena Čuklina, Gordon Graham, Habib Ganjgahi

Mult Scler· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A scalable approach for continuous time Markov models with covariates.
Farhad Hatami, Alex Ocampo, Gordon Graham, Thomas E Nichols, Habib Ganjgahi

Biostatistics· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment.
Stephen L Hauser, Ludwig Kappos, Amit Bar-Or, Heinz Wiendl, David Paling, Gordon Graham

Neurol Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale for Use of Sphingosine-1-Phosphate Receptor Modulators in COVID-19 Patients: Overview of Scientific Evidence.
Thomas Hach, Kasra Shakeri-Nejad, Marc Bigaud, Frank Dahlke, Massimiliano de Micco, Gordon Graham

J Interferon Cytokine Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetic-B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple Sclerosis.
Huixin Yu, Gordon Graham, Olivier J David, Joseph M Kahn, Marina Savelieva

CNS Drugs· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implantation of Acellular Nerve Allograft Using Nerve Connectors.
Jonathan Isaacs, Satya Mallu, Gaurangkumar Patel, Amy Kite, Sagar Shah, Gordon P Graham

Hand (N Y)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does partial muscle reinnervation preserve future re-innervation potential?
Jonathan Isaacs, Satya Mallu, Mary Shall, Gaurangkumar Patel, Pooja Shah, Gordon Graham

Muscle Nerve· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of IND/GLY (indacaterol/glycopyrronium) in COPD patients.
Ivan Demin, Christian Bartels, Gordon Graham, Bruno Bieth, Aurélie Gautier

Int J Clin Pharmacol Ther· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mammals of Australia's tropical savannas: a conceptual model of assemblage structure and regulatory factors in the Kimberley region.
Ian J Radford, Christopher R Dickman, Antony N Start, Carol Palmer, Karin Carnes, Gordon Graham

PLoS One· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D deficiency and insufficiency after pediatric liver transplantation.
Maria Legarda, Graham Gordon, Carla Lloyd, Ulrich Baumann, Deirdre A Kelly

Pediatr Transplant· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the pre-posterior distribution of optimized sampling times for the design of pharmacokinetic studies.
Stephen B Duffull, Gordon Graham, Kerrie Mengersen, John Eccleston

J Biopharm Stat· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics and optimal design of paediatric studies for famciclovir.
Kayode Ogungbenro, Ivan Matthews, Michael Looby, Guenther Kaiser, Gordon Graham

Br J Clin Pharmacol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining MCMC with 'sequential' PKPD modelling.
David Lunn, Nicky Best, David Spiegelhalter, Gordon Graham, Beat Neuenschwander

J Pharmacokinet Pharmacodyn· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian sample size for exploratory clinical trials incorporating historical data.
John Whitehead, Elsa Valdés-Márquez, Patrick Johnson, Gordon Graham

Stat Med· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incorporating correlation in interindividual variability for the optimal design of multiresponse pharmacokinetic experiments.
Kayode Ogungbenro, Gordon Graham, Ivelina Gueorguieva, Leon Aarons

J Biopharm Stat· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Filaggrin mutations are genetic modifying factors exacerbating X-linked ichthyosis.
Haihui Liao, Alex J Waters, David R Goudie, David A Aitken, Gordon Graham

J Invest Dermatol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal design for multiresponse pharmacokinetic-pharmacodynamic models - dealing with unbalanced designs.
Kayode Ogungbenro, Ivelina Gueorguieva, Oneeb Majid, Gordon Graham, Leon Aarons

J Pharmacokinet Pharmacodyn· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A program for individual and population optimal design for univariate and multivariate response pharmacokinetic-pharmacodynamic models.
Ivelina Gueorguieva, Kayode Ogungbenro, Gordon Graham, Sophie Glatt, Leon Aarons

Comput Methods Programs Biomed· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimum blood sampling time windows for parameter estimation in population pharmacokinetic experiments.
Gordon Graham, Leon Aarons

Stat Med· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sample size calculations based on generalized estimating equations for population pharmacokinetic experiments.
Kayode Ogungbenro, Leon Aarons, Gordon Graham

J Biopharm Stat· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of a modified Fedorov exchange algorithm to optimise sampling times for population pharmacokinetic experiments.
Kayode Ogungbenro, Gordon Graham, Ivelina Gueorguieva, Leon Aarons

Comput Methods Programs Biomed· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A program for the optimum design of pharmacokinetic, pharmacodynamic, drug metabolism and drug-drug interaction models.
Gordon Graham, Ivelina Gueorguieva, Kelly Dickens

Comput Methods Programs Biomed· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New pressure flow cell to monitor BaSO4 precipitation using synchrotron in situ angle-dispersive X-ray diffraction.
Alison Hennessy, Gordon Graham, Jerry Hastings, D Peter Siddons, Zhong Zhong

J Synchrotron Radiat· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of an optimal dosage regimen using a Bayesian decision analysis of efficacy and adverse effect data.
Gordon Graham, Suneel Gupta, Leon Aarons

J Pharmacokinet Pharmacodyn· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis